| PEB0164 | Epidemiology of Human Papillomavirus genotypes and prevalence of cervical precancerous lesions among women living with HIV: Results from a pilot cervical cancer screening program in Uganda | E-poster | B14 |
| PEB0165 | Discover study for HIV Pre-Exposure Prophylaxis (PrEP): No evidence of risk compensation in participants taking F/TDF or F/TAF for PrEP through 96 weeks | E-poster | B14 |
| PEB0166 | Anal cytological abnormalities and HPV detection with different primer sets in HIV-positive men in eastern India | E-poster | B14 |
| PEB0167 | Clinical prediction of Chlamydia trachomatis and Neisseria gonorrhea among adolescents and young adults living with HIV in Eswatini | E-poster | B14 |
| PEB0168 | A multi-country comparative study of two treponemal tests for the serodiagnosis of Syphilis amongst Men Who Have Sex with Men (MSM): Chemo-Luminescent Assay vs Treponema Pallidum Particle Agglutination | E-poster | B14 |
| PEB0169 | Performance of self-collected specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infection | E-poster | B14 |
| PEB0170 | Frequency of detectable HIV viremia and immune suppression episodes as determinants of neurocognitive dysfunction in Ugandans with chronic HIV infection | E-poster | B15 |
| PEB0171 | Neurocognitive function assessed via a self-administered tablet-based digital platform among people with HIV seeking adult clinical care | E-poster | B15 |
| PEB0172 | The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: Evolution of neurocognitive diagnosis from baseline to two years follow-up | E-poster | B15 |
| PEB0173 | Tryptophane metabolites predict neurocognitive impairment and side effects during efavirenz | E-poster | B15 |